These data also further support that KRAS mutations confer cells increased capacity for autophagy induction and that efficiently countering this effect can be achieved only by decreasing mutant KRAS protein levels below a certain threshold, as we observed in the CRC cell lines. This evidence concerns the gene KRAS and colorectal carcinoma.